Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Insider trading at diaDexus, Inc. (DDXS) refers to stock transactions executed by corporate insiders—officers, directors, and shareholders owning more than 10% of the company. Over the past 90 days, 13 insiders have filed 29 transactions totaling $129.2K in trading activity. The most active insider is Life Sciences Capital Fund Lp Burrill (Executive), contributing $87.2K across 7 transactions.
diaDexus, Inc. insiders are currently net buyers of DDXS stock, showing neutral sentiment over the past 90 days. Executives have purchased $87.2K while selling $42.0K, resulting in a positive net flow of $45.2K. This buying activity represents 67% of total transaction volume.
diaDexus, Inc. has 13 active insiders who have filed SEC Form 4 transactions in the past 90 days. Life Sciences Capital Fund Lp Burrill (Executive) leads with 7 transactions totaling $87.2K. Bros. Capital (gp), Llc Baker (Executive) follows with 3 transactions worth $42.0K. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.
The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. diaDexus, Inc.'s current score of 67/100 indicates neutral insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $87.2K in purchases versus $42.0K in sales.
The most recent insider transaction occurred on Feb 5, 2015, when F. Rafield Lori Phd (Executive) acquired 218,182 shares at $0.00 per share for $0. This appears to be a discretionary trade.
Based on SEC Form 4 filings from the past 90 days, DDXS insider trading sentiment is currently neutral with an Alignment Score of 67/100. The net insider flow of $45.2K reflects accumulation, with 67% of volume being purchases.
SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like diaDexus, Inc.. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At DDXS, we track all Form 4 filings—currently showing 29 transactions from 13 insiders over 90 days.
A 10b5-1 plan allows diaDexus, Inc. executives to pre-schedule stock sales when they don't possess material non-public information. At DDXS, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at DDXS appears discretionary, making insider signals more meaningful.
You can monitor diaDexus, Inc. (DDXS) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 13 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.
Insider trading at diaDexus, Inc. (DDXS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of shares. These individuals must report trades to the SEC within two business days. Currently, 13 insiders are actively trading DDXS stock, having executed 29 transactions in the past 90 days. The most active insider is Life Sciences Capital Fund Lp Burrill (Executive), with 7 transactions totaling $87.2K.
Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. diaDexus, Inc.'s current score of 67/100 indicates moderately bullish sentiment suggesting insider confidence. This is calculated from $87.2K in purchases versus $42.0K in sales over 90 days, resulting in a net flow of $45.2K.
SEC Form 4 filings are mandatory reports that diaDexus, Inc. insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At DDXS, the most common type is "A" with 7 occurrences. The most recent Form 4 was filed on Feb 5, 2015 by F. Rafield Lori Phd.
Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At diaDexus, Inc., approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at DDXS represents discretionary decisions with more informational value.
Set alerts for diaDexus, Inc. and 40,000+ other insiders.